Search AMIA.org

This work highlights successes and challenges of implementing a novel responsible artificial intelligence (RAI) framework, emphasizing healthcare disciplines needed to operationalize it.

Neurofibromatosis type 1 (NF1) is a rare genetic disorder affecting multiple organ systems with significant clinical heterogeneity. Managing individuals with NF1 is challenging due to variability in disease progression and outcomes and limited early risk assessment tools.

Effective communication is crucial in healthcare, and for patients with a non-English language preference (NELP), professional interpreters are recognized as the gold standard in supporting bidirectional communication. However, interpreters are not always readily available, prompting the exploration of other options for translation and interpretation. The recent developments in artificial intelligence-based neural network translation tools, namely neural machine translation (NMT) may enable robust interpretation and translation.

Immunotherapy has emerged as a promising treatment for advanced non-small cell lung cancer (NSCLC), but accurately predicting which patients will benefit from it remains a major clinical challenge. To address this, we aim to develop a novel multimodal method, DeepAFM, that integrates histopathology, genomic features, and clinical information to predict patient responses to anti-PD-(L)1 immunotherapy.

Infections following healthcare-associated interventions drive patient morbidity and mortality, making early detection essential. Traditional predictive models utilize preoperative surgical characteristics. This study evaluated whether integrating postoperative laboratory values and their kinetics could improve outcome prediction.

Pediatric hospital readmissions increase healthcare costs and highlight gaps in care. Social determinants of health (SDOH), such as housing and transportation insecurity, significantly impact outcomes but are underexplored in pediatric populations.

The number of ethical frameworks designed to guide artificial intelligence (AI) use has grown substantially over the past decade, yet their real-world effect remains unclear. We aimed to synthesize existing evidence to analyze the practical impact of AI ethics frameworks (AIEFs) operationalized in healthcare.

To understand whether patients prefer chatbots for certain tasks in healthcare, and their motivations for doing so, recognizing that chatbots are already assisting patients with various healthcare tasks.